This weekend, The Telegraph-Journal reported on New Brunswick’s assets and capabilities in cancer research. Researchers here are advancing new methods for early detection and new treatments, and there is much promise for future breakthroughs.

For an overview of the institutions, companies, and support organizations making this happen, click here. The article highlights these key stakeholders who together provide the climate for new discovery:

• Atlantic Cancer Research Institute (ACRI)
• New Brunswick Health Research Foundation (NBHRF)
• Picomole Instruments
• Soricimed Biopharma
• BioAtlantech
• Tech South East
• Health and Life Sciences New Brunswick
• Genome Atlantic
• Strategic Directions Consulting (SDCI)

Post Tags